- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
67
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
67 companies
Laekna
Market Cap: HK$4.3b
An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis worldwide.
2105
HK$11.46
7D
23.0%
1Y
104.6%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$24.10
7D
0.4%
1Y
-13.3%
InnoCare Pharma
Market Cap: HK$18.2b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$8.83
7D
6.8%
1Y
104.9%
Uni-Bio Science Group
Market Cap: HK$406.0m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.068
7D
3.0%
1Y
-24.4%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$495.0m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.29
7D
9.3%
1Y
86.7%
China Resources Pharmaceutical Group
Market Cap: HK$30.6b
An investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.87
7D
-1.6%
1Y
3.8%
Grand Pharmaceutical Group
Market Cap: HK$19.5b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.56
7D
-5.6%
1Y
41.5%
XtalPi Holdings
Market Cap: HK$18.3b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$4.55
7D
5.1%
1Y
n/a
Ocumension Therapeutics
Market Cap: HK$3.9b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$4.77
7D
2.1%
1Y
-22.1%
TOT BIOPHARM International
Market Cap: HK$1.3b
An investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in China.
1875
HK$1.73
7D
1.8%
1Y
13.8%
Genor Biopharma Holdings
Market Cap: HK$1.1b
A biopharmaceutical company, focuses on developing and commercializing oncology and autoimmune drugs in China and internationally.
6998
HK$2.06
7D
4.0%
1Y
73.1%
Zhaoke Ophthalmology
Market Cap: HK$819.2m
An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, and Hong Kong.
6622
HK$1.50
7D
2.7%
1Y
-3.8%
Brii Biosciences
Market Cap: HK$1.3b
Engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.78
7D
8.5%
1Y
93.5%
JW (Cayman) Therapeutics
Market Cap: HK$587.6m
A clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People’s Republic of China.
2126
HK$1.45
7D
0.7%
1Y
-15.2%
Frontage Holdings
Market Cap: HK$2.4b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.17
7D
2.6%
1Y
-14.0%
Luye Pharma Group
Market Cap: HK$7.2b
An investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide.
2186
HK$1.91
7D
7.3%
1Y
-27.1%
Akeso
Market Cap: HK$74.5b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$82.95
7D
11.9%
1Y
82.7%
Jacobio Pharmaceuticals Group
Market Cap: HK$2.5b
An investment holding company, engages in the in-house discovery and development of oncology therapies.
1167
HK$3.14
7D
10.2%
1Y
106.6%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$5.8b
An investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$0.63
7D
3.3%
1Y
23.5%
Ascletis Pharma
Market Cap: HK$4.8b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$4.94
7D
2.5%
1Y
289.0%
Kontafarma China Holdings
Market Cap: HK$128.5m
An investment holding company, engages in the manufacture and sale of prescription drugs in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.023
7D
-4.2%
1Y
-32.4%
Austar Lifesciences
Market Cap: HK$410.1m
An investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.80
7D
-1.2%
1Y
-15.8%
Tong Ren Tang Technologies
Market Cap: HK$6.0b
Manufactures and sells Chinese medicine products in Mainland China and internationally.
1666
HK$4.67
7D
0%
1Y
-1.1%
Antengene
Market Cap: HK$1.8b
A biopharmaceutical company, engages in the development of novel oncology therapies in Greater China and internationally.
6996
HK$2.67
7D
9.9%
1Y
210.5%
CanSino Biologics
Market Cap: HK$10.5b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$29.50
7D
3.9%
1Y
66.5%
Keymed Biosciences
Market Cap: HK$11.8b
A biotechnology company, engages in the research and development of biological therapies for the treatment of autoimmunity and oncology diseases.
2162
HK$42.65
7D
4.5%
1Y
43.8%
Genscript Biotech
Market Cap: HK$22.5b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$10.40
7D
3.6%
1Y
-9.2%
Alphamab Oncology
Market Cap: HK$6.4b
A clinical stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of oncology biologics.
9966
HK$6.63
7D
11.8%
1Y
53.5%
China Regenerative Medicine International
Market Cap: HK$129.3m
An investment holding company, engages in the provision of healthcare products and services in Hong Kong and the People’s Republic of China.
8158
HK$0.42
7D
18.1%
1Y
51.8%
Beijing Biostar Pharmaceuticals
Market Cap: HK$1.6b
A synthetic biology-driven biopharmaceutical company, engages in the research and development, production, and commercialization of oncology products in the People’s Republic of China.
2563
HK$4.41
7D
0%
1Y
n/a
WuXi XDC Cayman
Market Cap: HK$38.2b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$31.85
7D
-0.2%
1Y
79.9%